Nerve graft trial for Parkinson's or MSA
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether grafting a piece of your own leg nerve into a specific part of the brain can improve symptoms of Parkinson's disease or multiple system atrophy (MSA). It aims to help people whose movement problems are moderate but not too severe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson's disease or multiple system atrophy (MSA) for at least 2 years.
- You are between 40 and 75 years old.
- Your movement symptoms are moderate when you are off your usual medication (a score between 20 and 35 on a standard rating scale).
- You are able to have a special brain scan (SPECT) and an MRI.
- You have not had any previous brain surgery for Parkinson's or other conditions.
- You are not taking blood thinners (other than aspirin) and are generally healthy enough for surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if implanting a small piece of your own leg nerve into the brain can improve Parkinson's symptoms. It is done at the same time as deep brain stimulation (DBS) surgery.
This trial tests whether a supplement called nicotinamide riboside (NR) can help people with rare forms of parkinsonism (PSP, MSA, or CBS). It is a double-blind study, meaning neither you nor the doctors will know if you are getting the real supplement or a placebo.
This study tests a new injection called NouvNeu001 for people with Multiple System Atrophy (MSA). The goal is to see if it can help control symptoms that standard treatments aren't managing well.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This study tests whether injecting special dopamine-producing brain cells can help slow or improve symptoms in people with multiple system atrophy, a rare movement disorder similar to Parkinson's disease. The trial combines cell transplantation with brain imaging to measure safety and effectiveness.
This trial tests whether a patient's own stem cells can help slow or improve symptoms of multiple system atrophy (MSA), a rare brain disorder. It may be an option for adults aged 35 to 65 with either the parkinsonian or cerebellar type of MSA.
Hear when a new Multiple System Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.